Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-026555

VP Finance & Accounting bought 2,300 shares at $9.00 ($20,700)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomson Peter G. VP Finance & Accounting 2021-06-28 Purchase +2,300 $9.00 $20,700 2,300 I: show line 1 in the form
Open-market purchases · 2,300 sh · avg $9.00 · $20,700
Loading xslF345X03/doc4.xml…